Understanding cognitive and emotional profiles in Multiple Sclerosis
The MS-CEBA Study: Determining Cognitive, Energetic, Behavioural and Affective (CEBA) Profiles in Multiple Sclerosis
This study is trying to understand how thinking and feeling differently affects the daily lives of people with Multiple Sclerosis to help improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | University Medical Center Groningen Academic / other |
| Locations | 1 site (Groningen, Provincie Groningen) |
| Trial ID | NCT06016309 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the cognitive, energetic, behavioral, and affective (CEBA) profiles in individuals diagnosed with Multiple Sclerosis (MS). It focuses on identifying non-physical symptoms that significantly impact the quality of life and societal participation of patients. By conducting neuropsychological assessments, the study seeks to highlight the prevalence and interrelation of CEBA symptoms among patients with MS, which are often overlooked in traditional treatment approaches. The findings may help in recognizing these symptoms earlier and improving treatment strategies for affected individuals.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18-70 with a confirmed diagnosis of Multiple Sclerosis who can communicate adequately in Dutch.
Not a fit: Patients with other neurological or major psychiatric conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better recognition and treatment of non-physical symptoms in MS, enhancing patients' quality of life.
How similar studies have performed: While studies have explored cognitive and emotional aspects in MS, this specific focus on CEBA profiles is relatively novel and may provide new insights.
Eligibility criteria
Show full inclusion / exclusion criteria
In order to be eligible to participate in this study, a patient must meet all of the following criteria: Inclusion Criteria: * Confirmed MS diagnosis (all subtypes); * Age18-70; * Adequate command of the Dutch language. Exclusion Criteria: * Not being able to participate in a short neuropsychological assessment (NPA) as judged by the MS clinician and/or investigator; * Presence of any other neurological and/or major psychiatric condition. The group of HC's will be matched to the patient group on age and education level.
Where this trial is running
Groningen, Provincie Groningen
- University Medical Center Groningen (UMCG) — Groningen, Provincie Groningen, Netherlands (Recruiting)
Study contacts
- Principal investigator: Joke Spikman, Prof. Dr. — Department of Neurology - Unit Neuropsychology of the University Medical Center Groningen (UMCG)
- Study coordinator: Anniek Reinhardt, MSc./Drs.
- Email: a.reinhardt@umcg.nl
- Phone: +3150 3619431
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.